BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thevis M, Kuuranne T, Geyer H. Annual banned-substance review: Analytical approaches in human sports drug testing 2019/2020. Drug Test Anal 2021;13:8-35. [PMID: 33185038 DOI: 10.1002/dta.2969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Velosa DC, Dunham AJ, Rivera ME, Neal SP, Chouinard CD. Improved Ion Mobility Separation and Structural Characterization of Steroids using Derivatization Methods. J Am Soc Mass Spectrom 2022. [PMID: 35914213 DOI: 10.1021/jasms.2c00164] [Reference Citation Analysis]
2 Berger BK, Wicker AP, Preuss EK, Fujito Y, Hedgepeth W, Nishimura M, Schug KA. Streamlined stationary phase selection facilitated by a “sample-plug retention test” in supercritical fluid extraction-supercritical fluid chromatography-mass spectroscopy (SFE-SFC-MS) method development for on-line extraction of anabolic agents. Journal of Liquid Chromatography & Related Technologies. [DOI: 10.1080/10826076.2022.2098319] [Reference Citation Analysis]
3 González-Rubio S, Ballesteros-Gómez A, Muñoz G, Rubio S. Cubosomic Supramolecular Solvents: Synthesis, Characterization, and Potential for High-Throughput Multiclass Testing of Banned Substances in Urine. Anal Chem 2022. [PMID: 35191686 DOI: 10.1021/acs.analchem.2c00082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Krombholz S, Thomas A, Thevis M. Investigations into the In Vitro Metabolism of hGH and IGF-I Employing Stable-Isotope-Labelled Drugs and Monitoring Diagnostic Immonium Ions by High-Resolution/High-Accuracy Mass Spectrometry. Metabolites 2022;12:146. [DOI: 10.3390/metabo12020146] [Reference Citation Analysis]
5 Xie Y, Tian Y, Zhang Y, Zhang Z, Chen R, Li M, Tang J, Bian J, Li Z, Xu X. Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998–2021). European Journal of Medicinal Chemistry 2022;230:114119. [DOI: 10.1016/j.ejmech.2022.114119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Koomen DC, May JC, McLean JA. Insights and prospects for ion mobility-mass spectrometry in clinical chemistry. Expert Rev Proteomics 2022;:1-15. [PMID: 34986717 DOI: 10.1080/14789450.2022.2026218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Watson CJ, Stone GL, Overbeek DL, Chiba T, Burns MM. Performance-enhancing drugs and the Olympics. J Intern Med 2022;291:181-96. [PMID: 35007384 DOI: 10.1111/joim.13431] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Velosa DC, Rivera ME, Neal SP, Olsen SSH, Burkus-Matesevac A, Chouinard CD. Toward Routine Analysis of Anabolic Androgenic Steroids in Urine Using Ion Mobility-Mass Spectrometry. J Am Soc Mass Spectrom 2021. [PMID: 34936363 DOI: 10.1021/jasms.1c00231] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
9 Thevis M, Kuuranne T, Geyer H. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021. Drug Test Anal 2021. [PMID: 34788500 DOI: 10.1002/dta.3199] [Reference Citation Analysis]
10 Lima G, Kolliari-Turner A, Malinsky FR, Guppy FM, Martin RP, Wang G, Voss SC, Georgakopoulos C, Borrione P, Pigozzi F, Pitsiladis Y. Integrating Whole Blood Transcriptomic Collection Procedures Into the Current Anti-Doping Testing System, Including Long-Term Storage and Re-Testing of Anti-Doping Samples. Front Mol Biosci 2021;8:728273. [PMID: 34765642 DOI: 10.3389/fmolb.2021.728273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Krombholz S, Thomas A, Piper T, Lagojda A, Kühne D, Thevis M. Urinary phenylethylamine metabolites as potential markers for sports drug testing purposes. Biomed Chromatogr 2021;:e5274. [PMID: 34729800 DOI: 10.1002/bmc.5274] [Reference Citation Analysis]
12 Thevis M, Kuuranne T, Fedoruk M, Geyer H. Sports drug testing and the athletes' exposome. Drug Test Anal 2021. [PMID: 34694748 DOI: 10.1002/dta.3187] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Saad K, Salama S, Horvatovich P, Al Maadheed M, Georgakopoulos C. Olympic anti-doping laboratory: the analytical technological road from 2016 Rio De Janeiro to 2021 Tokyo. Bioanalysis 2021;13:1511-27. [PMID: 34617444 DOI: 10.4155/bio-2021-0157] [Reference Citation Analysis]
14 Lima G, Muniz-Pardos B, Kolliari-Turner A, Hamilton B, Guppy FM, Grivas G, Bosch A, Borrione P, DI Gianfrancesco A, Fossati C, Pigozzi F, Pitsiladis Y. Anti-doping and other sport integrity challenges during the COVID-19 pandemic. J Sports Med Phys Fitness 2021;61:1173-83. [PMID: 34256541 DOI: 10.23736/S0022-4707.21.12777-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Thevis M, Kuuranne T, Thomas A, Geyer H. Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings. Drug Test Anal 2021;13:505-9. [PMID: 33538088 DOI: 10.1002/dta.3011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]